Home › Chronic Granulomatous Disease › Maryland
Chronic Granulomatous Disease clinical trials in Maryland
6 studies for Chronic Granulomatous Disease are looking for participants at sites in Maryland.
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 18 to 75 · Men · Updated Oct 2, 2026 · NCT05189925Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1/2
Ages 4 to 65 · All sexes · Updated Oct 2, 2026 · NCT05463133Evaluation of Patients With Immune Function Abnormalities
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Sep 22, 2026 · NCT00128973Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Sep 22, 2026 · NCT00001405Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
- Home-based telemedicine, Annapolis
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT06605378Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1/2
Ages 18 to 75 · Men · Updated Aug 13, 2026 · NCT06325709From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.